Hotel Indigo

Sanguine agrees US takeover

North West hotel entrepreneur Simon Matthews-Williams has sold the management division of Sanguine Hospitality, which he established in 2006, to US-based Interstate Hotels & Resorts for an undisclosed sum.

The deal includes management agreements for 14 hotels in the UK, nine trading and five in development. Liverpool-based Sanguine is a franchisee that runs hotels under license from international brands. Its assets include Hotel Indigo Liverpool; Days Inn Liverpool; Doubletree by Hilton Liverpool; Doubletree by Hilton Chester; Days Hotel Chester North; Holiday Inn Express Hoylake.

The development division is unaffected by the deal. Sanguine's management division was owned by Matthews-Williams, chairman, Nick Taplin, managing director, and Caroline Wilce, finance director.

Jim Abrahamson, chief executive officer of Interstate Hotels & Resorts, said: "It's incredibly gratifying to see Interstate's global footprint continue to grow, delivering on our overall expansion strategy.

"As full UK operations join our established Interstate Europe platform in Russia and continental Europe, we look forward to our alliance with Sanguine and their exceptional teams. This relationship strategically positions Interstate for abundant future growth and opportunities throughout the region, and our global operating experience paired with long-standing, beneficial relationships with top international brands promise a successful future between Interstate and Sanguine."

Matthews-Williams added: "While we have enjoyed significant success through organic growth and a strong market reputation, our new relationship with Interstate puts us on an entirely new level and provides a platform to achieve step-change growth. From our initial meetings, it was clear that Interstate identified Sanguine as a progressive, successful and ambitious business. We are confident that this is the right move at the right time, not just for the business, but also for our excellent staff and loyal customers across our portfolio."

Law firm Fladgate LLP advised Sanguine.

Your Comments

Subscribe to our newsletter